A natural small molecule induces megakaryocytic differentiation and suppresses leukemogenesis through activation of PKCδ/ERK1/2 signaling pathway in erythroleukemia cells
Autor: | Li Chen, Yong Hu, Jue Yang, Song Jingrui, Qing Rao, Qiu Jianfei, Wei Gu, Juan Chen, Qun Long, Xiao-Jiang Hao, Yanmei Li, Yongqiang Zhang |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
0301 basic medicine
Cell cycle checkpoint Carcinogenesis MAP Kinase Signaling System Kaempferol 3-O-α-L-(4″-E-p-coumaroyl) rhamnoside Cyclocarya paliurus Apoptosis RM1-950 Models Biological Flow cytometry Small Molecule Libraries 03 medical and health sciences Inhibitory Concentration 50 0302 clinical medicine medicine Humans Viability assay Glycosides Kaempferols Pharmacology Leukemia medicine.diagnostic_test Cell growth Chemistry Plant Extracts Cell Differentiation General Medicine Cell Cycle Checkpoints Megakaryocytic differentiation PKCδ/ERK1/2 signaling pathway Cell biology Plant Leaves Protein Kinase C-delta 030104 developmental biology 030220 oncology & carcinogenesis Phosphorylation Therapeutics. Pharmacology Signal transduction K562 Cells Megakaryocytes K562 cells Erythroleukemia |
Zdroj: | Biomedicine & Pharmacotherapy, Vol 118, Iss, Pp-(2019) |
ISSN: | 0753-3322 |
Popis: | Kaempferol-3-O-rhamnoside (KOR) has multiple potency involved in anti-cancer, anti-inflammatory and antibacterial actions. However, the potential roles of KOR and the analogues isolated from the leaves of Cyclocarya paliurus in anti-erythroleukemia remain unclear. In the present study, KOR and the two analogues (Kaempferol-3-O-(4″-O-acetyl-a-L-rhamnopyranoside) (KLR) and (kaempferol-3-O-α-L-(4″-E-p-coumaroyl) rhamnoside) (KCR) were isolated from leaves of Cyclocarya paliurus. Cell viability assay showed that KCR exerted an excellent anti-erythroleukemia activity. We observed that KCR not only significantly increased the percentage of G2 phase and apoptotic cells compared with control group, but also induced megakaryocytic differentiation in HEL and K562 cells by flow cytometry, indicating that KCR might inhibit cell proliferation through inducing differentiation-mediated apoptosis and cell cycle arrest. Mechanism investigation revealed that KCR treatment obviously increased phosphorylation levels of PKCδ and ERK1/2 as well as GATA1 expression. Taken together, these findings demonstrate that KCR induces megakaryocytic differentiation and suppresses leukemogenesis at least partly through activation of PKCδ/ERK1/2 signaling pathway in erythroleukemia cells. KCR may also serve as a promising natural compound for human erythroleukemia treatment. |
Databáze: | OpenAIRE |
Externí odkaz: |